AstraZeneca gets US, EU approvals for treatment of autoimmune disorder
(Alliance News) - AstraZeneca PLC on Monday announced that Alexion's Klygefa treatment received approval in both the US and EU for adults with generalised myasthenia gravis, a rare autoimmune disorder that causes severe muscle weakness. Read More